Drug Delivery by Ultrasound-Responsive Nanocarriers for Cancer Treatment
SATB1 as oncogenic driver and potential therapeutic target in head & neck squamous cell carcinoma (HNSCC) | Scientific Reports
Cell-type specific and non-redundant anti-proliferative effects of shRNA-mediated Galpha12- and Galpha13 knockdown in lung canc
Vorlage Geschäftsbrief mit Siegel
Curriculum vitae
Mitarbeiter des Rudolf-Boehm-Institutes
Influence of nanoparticle-mediated transfection on proliferation of primary immune cells in vitro and in vivo | PLOS ONE
Achim Aigner | Leipzig University, Germany | Pharmaceutica 2017 | Conferenceseries
Leipziger Pharmakologen forschen an Molekülen gegen Prostatakrebs
PEI-complexed LNA antiseeds as miRNA inhibitors
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology
Tau Silencing by siRNA in the P301S Mouse Model of Tauopathy
Impact of medication on blood transcriptome reveals off-target regulations of beta-blockers | PLOS ONE
Polyethylenimine Nanoparticle-Mediated siRNA Delivery to Reduce α-Synuclein Expression in a Model of Parkinson's D
فلسفي دافئ تحويلات بند تشابه لفة aigner et al 2011 - afsassociation.org
Mitarbeiter des Rudolf-Boehm-Institutes
European Technology Platform on Nanomedicine
Front Cover: Balancing Histone Deacetylase (HDAC) Inhibition and Drug‐likeness: Biological and Physicochemical Evaluation of Class I Selective HDAC Inhibitors (ChemMedChem 9/2022) - Schäker‐Hübner - 2022 - ChemMedChem - Wiley Online Library
Evaluation of Colon-Specific Plasma Nanovesicles as New Markers of Colorectal Cancer
Silencing of Neuropilins and GIPC1 in pancreatic ductal adenocarcinoma exerts multiple cellular and molecular antitumor effects | Scientific Reports
Exploring the MIR143-UPAR Axis for the Inhibition of Human Prostate Cancer Cells In Vitro and In Vivo: Molecular Therapy - Nucleic Acids
